CEBPA and fatty liver disease: Based on these studies of C/EBPα‐p300 complexes and data of ChIP assay, we conclude that the C/EBPα‐p300 complexes are not accumulated in old KO mice and that this leads to the lack of activation of the DGAT1 promoter and prevention of hepatic steatosis associated with aging.